Drug Information Association Conference To Explore Global Pharmacovigilance And Risk Management Strategies And Regultory Frameworks The field of medical product safety continues to grow in complexity, with both clinical trial safety and post-marketing pharmacovigilance becoming ever more critical in the development and marketed use of medical products. In response, the Drug Information Association (DIA) will host
Source: www.medicalnewstoday.comMany Female Veterans Report Military Sexual Trauma; Military Sexual Trauma Is Linked To Higher Rates Of Mental Health Problems According to preliminary research results from the Department of Veterans Affairs, approximately 15 percent of recently returned female veterans utilizing the VA
health care system report experiencing sexual trauma during military service.
Source: www.medicalnewstoday.comSunesis Announces Updated Clinical Data Of Voreloxin In Platinum-Resistant Ovarian Cancer Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
Source: www.medicalnewstoday.comCIMZIA(R) (Certolizumab Pegol) Provides Rapid And Sustained Relief From Signs And Symptoms Of Rheumatoid Arthritis For Two Years UCB announced results from several Phase III clinical trials evaluating CIMZIA(R) (certolizumab pegol) - the only PEGylated anti-TNF (Tumor Necrosis Factor) - presented at the American College of Rheumatology (ACR) Annual Scientific Meeting.
Source: www.medicalnewstoday.comCommonwealth Must Not Abandon Mentally Ill, Australian Medical Association AMA (Australian Medical Association) President, Dr Rosanna Capolingua, today said indications that the Commonwealth Government is backing away from mental
health have set alarm bells ringing. "People with mental illnesses and their families deserve Federal Government support and commitment - this is not the time to abandon an intense focus on mental
health," Dr Capolingua said.
Source: www.medicalnewstoday.comBIO-Europe 2008 To Get Biotech Industry Partnerships Started In Challenging Economic Environment In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 17-19 in Mannheim/Heidelberg, Germany for BIO-Europe 2008, the world's largest stand-alone partnering conference.
Source: www.medicalnewstoday.comEmployers Must Work On Mental Health, UK As the first of the Government's measures to get people back to work are introduced today (Monday 27 October), Mind reveals shocking new evidence that employers are not willing to take on people who have experience of mental distress and that they are failing staff by not providing adequate mental
health support.
Source: www.medicalnewstoday.comACTEMRA (R) (tocilizumab) Significantly Reduced Signs And Symptoms Of Rheumatoid Arthritis In Patients Who Failed Prior Treatments Data from two Phase III studies showed that patients who suffer from the debilitating and painful effects of rheumatoid arthritis (RA) achieved significant improvements in signs and symptoms when treated with ACTEMRA(R) (tocilizumab) alone or in combination with methotrexate compared with methotrexate alone.
Source: www.medicalnewstoday.comLong-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir As Part Of HIV Combination Therapy In Treatment-Naive Adults Ninety-six week results presented from a phase 3, randomized, open-label, ongoing clinical trial showed that 79 percent of treatment-naive HIV-1 infected adults taking PREZISTA(R) 800 mg (two 400 mg tablets) with 100 mg ritonavir (r) once daily reached an undetectable viral load (
Source: www.medicalnewstoday.comCovert Promotion Of Off-Label Drug Use Several techniques are often employed by drug companies to secretly promote off-label use, according to a piece released on October 27, 2008 in the open-access journal PLoS
Medicine. For most
drugs, it is legal to prescribe them for off-label uses, which are not specified in the original approval of the drug. These uses are sometimes unavoidable -- for instance, most approvals do not include pregnant women, who may need medication.
Source: www.medicalnewstoday.com
# posted by Network @ 8:00 AM
